but with less risk of bioprosthetic valve dysfunction, in patients with small annuli and symptomatic severe aortic stenosis. Presenting the data here at CRT 2025, SMART lead Investigator Howard ...
It is also the first to focus specifically on informing device selection for patients with small aortic annuli ... valve that has become too narrow and does not fully open, forcing the heart ...
Medtronic says its Evolut TAVR shows strong valve performance and durable outcomes at 5 years in low-risk aortic stenosis ...
(RTTNews) - Medtronic plc (MDT) released the two-year results of the SMall Annuli Randomized ... disabling stroke, and heart failure hospitalization, and continued superior valve performance ...
Medtronic plc MDT recently unveiled two-year Small Annuli Randomized to Evolut or SAPIEN ... trial of transfemoral transcatheter aortic valve replacement ("TAVR"), conducted in patients ...
At one-year, clinical safety outcomes show positive results with no valve or cardiovascular related mortality and importantly no prosthesis-patient mismatch (PPM*) reported in these small annuli ...